Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir

Journal of the National Cancer Institute

Volumn 98, Issue 4, 2006, Pages 236-244

  Alexandre, Jérôme ^a,b   Nicco, Carole ^a   Chéreau, Christiane ^a   Laurent, Alexis ^a   Weill, Bernard ^a   Goldwasser, François ^a   Batteux, Frédéric ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Groupe Hospitalier Cochin Saint Vincent de Paul ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CATALASE; DOCETAXEL; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE REDUCTASE; HYDROGEN PEROXIDE; MANGAFODIPIR; OXALIPLATIN; PACLITAXEL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BLOOD CELL COUNT; CANCER CELL; CELL VIABILITY; COLON CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOLYSIS; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LEUKOPENIA; MOUSE; MOUSE STRAIN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; SURVIVAL RATE; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATALASE; CELL LINE, TUMOR; CELL SURVIVAL; COLONIC NEOPLASMS; CONFIDENCE INTERVALS; DRUG SYNERGISM; EDETIC ACID; FEMALE; FLUOROURACIL; GLUTATHIONE REDUCTASE; HUMANS; HYDROGEN PEROXIDE; LEUKOCYTES; MICE; MICE, INBRED BALB C; ORGANOPLATINUM COMPOUNDS; OXIDATIVE STRESS; PACLITAXEL; PYRIDOXAL PHOSPHATE; REACTIVE OXYGEN SPECIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 33144488485     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/djj049     Document Type: Article

References (32)

1. 2 for platelet-derived growth factor signal transduction. Science 1995; 270: 296-9.
2. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389: 300-5.
3. Bernard D, Gosselin K, Monte D, Vercamer C, Bouali F, Pourtier A, et al. Involvement of Rel/nuclear factor-κB transcription factors in keratinocyte senescence. Cancer Res 2004; 64: 472-81.
4. Hwang PM, Bunz F, Yu J, Rago C, Chan TA, Murphy MP, et al. Ferredoxin reductase affects p53-dependent, 5-fluorouracil-induced apoptosis in colorectal cancer cells. Nat Med 2001; 7: 1111-7.
5. Benhar M, Dalyot I, Engelberg D, Levitzki A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol Cell Biol 2001; 21: 6913-26.
6. Laurent A, Nicco C, Chéreau C, Goulvestre C, Alexandre J, Alves A, et al. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 2005; 65: 948-56.
7. Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 1999; 94: 2102-11.
8. Alexandre J, Batteux F, Nicco C, Chereau C, Laurent A, Weill B, et al. The accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int J Cancer. In press.
9. Hussain SP, Amstad P, He P, Robles A, Lupold S, Kaneko I, et al. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 2004; 64: 2350-6.
10. Hirpara JL, Clement MV, Pervaiz S. Intracellular acidification triggered by mitochondrial-derived hydrogen peroxide is an effector mechanism for drug-induced apoptosis in tumor cells. J Biol Chem 2001; 276: 514-21.
11. Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004; 7: 97-110.
12. Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines. Cancer Res 1993; 53: 5225-32.
13. Skapek SX, Colvin OM, Griffith OW, Elion GB, Bigner DD, Friedman HS. Enhanced melphalan cytotoxicity following buthionine sulfoximine-mediated glutathione depletion in a human medulloblastoma xenograft in athymic mice. Cancer Res 1988; 48: 2764-7.
14. Bailey HH, Mulcahy RT, Tutsch KD, Arzoomanian RZ, Alberti D, Tombes MB, et al. Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: An attempt at modulation of glutathione. J Clin Oncol 1994; 12: 194-205.
15. Bailey HH, Ripple G, Tutsch KD, Arzoomanian RZ, Alberti D, Feierabend C, et al. Phase I study of continuous-infusion L-S,R-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst 1997; 89: 1789-96.
16. Cullen JJ, Weydert C, Hinkhouse MM, Ritchie J, Domann FE, Spitz D, et al. The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 2003; 63: 1297-303.
17. Zhang Y, Zhao W, Zhang HJ, Domann FE, Oberley LW. Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth. Cancer Res 2002; 62: 1205-12.
18. Bedda S, Laurent A, Conti F, Chereau C, Tran A, Tran-Van Nhieu J, et al. Mangafodipir prevents liver injury induced by acetaminophen in the mouse. J Hepatol 2003; 39: 765-72.
19. Leuthauser SW, Oberley LW, Oberley TD, Sorenson JR, Ramakrishna K. Antitumor effect of a copper coordination compound with superoxide dismutase-like activity. J Natl Cancer Inst 1981; 66: 1077-81.
20. Patel M, Day BJ. Metalloporphyrin class of therapeutic catalytic antioxidants. Trends Pharmacol Sci 1999; 20: 359-64.
21. Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: Its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6: 593-7.
22. Alexandre J, Rey E, Dieras V, Grabar S, Tran A, Montheil V, et al. Prospective study of predictive factors of docetaxel (DCX)-induced febrile neutropenia (FN): Relevance of in vivo cytochrome 3A (CYP3A) phenotyping. Proc Am Soc Clin Oncol 2005; abstr 2046.
23. Rice GC, Bump EA, Shrieve DC, Lee W, Kovacs M. Quantitative analysis of cellular glutathione by flow cytometry utilizing monochlorobimane: Some applications to radiation and drug resistance in vitro and in vivo. Cancer Res 1986; 46: 6105-10.
24. Neuwelt EA, Pagel MA, Hasler BP, Deloughery TG, Muldoon LL. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model. Cancer Res 2001; 61: 7868-74.
25. Samlowski WE, Petersen R, Cuzzocrea S, Macarthur H, Burton D, McGregor JR, et al. Nonpeptidyl mimic of superoxide dismutase, M40403, inhibits dose-limiting hypotension associated with interleukin-2 and increases its antitumor effects. Nat Med 2003; 9: 750-5.
26. Macarthur H, Westfall TC, Riley DP, Misko TP, Salvemini D. Inactivation of catecholamines by superoxide gives new insights on the pathogenesis of septic shock. Proc Natl Acad Sci U S A 2000; 97: 9753-8.
27. Esco R, Valencia J, Coronel P, Carceller JA, Gimeno M, Bascon N. Efficacy of orgotein in prevention of late side effects of pelvic irradiation: A randomized study. Int J Radiat Oncol Biol Phys 2004; 60: 1211-9.
28. Carew JS, Zhou Y, Albitar M, Carew JD, Keating MJ, Huang P. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: Clinical significance and therapeutic implications. Leukemia 2003; 17: 1437-47.
29. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, et al. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 1997; 275: 1649-52.
30. Jaruga P, Zastawny TH, Skokowski J, Dizdaroglu M, Olinski R. Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer. FEBS Lett 1994; 341: 59-64.
31. Li S, Yan T, Yang JQ, Oberley TD, Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 2000; 60: 3927-39.
32. Federle MP, Chezmar JL, Rubin DL, Weinreb JC, Freeny PC, Semelka RC, et al. Safety and efficacy of mangafodipir trisodium injection for hepatic MRI in adults; results of the US multicenter phase III clinical trials. J Magn Reson Imaging 2000; 12: 186-97.